To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open6,556
High6,662.5
Low6,552
Prev. Close6,595.5
Avg. Traded Price6,604.67
Volume2,08,301

MARKET DEPTH

info2
Total bid0.00
Total ask31.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
6595.5231
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

6,552.0018 hours ago
6,662.5018 hours ago
arrow

LOWER/UPPER CIRCUITS

5,985.00
7,315.00
arrow
Divis Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 18.67%, in the last year to ₹9,712 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 36.94% in the last year to ₹2,191 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
noteQuarterly Revenue,rose 12.24% YoY to ₹2,671 Cr. Its sector's average revenue growth YoY for the quarter was 10.76%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 15.13%
Net profit growth 5Y CAGR : 3.41%

STOCK RETURNS

info
Versus Nifty 50
1 w
-0.44%
vs
-1.52%
1 mth
-3.31%
vs
-3.28%
3 mth
+7.79%
vs
+1.42%
6 mth
+17.15%
vs
+6.55%
1 yr
+33.72%
vs
-0.62%
3 yr
+71.83%
vs
+43.84%
5 yr
+171.66%
vs
+120.31%
Divis Laboratories Ltd Top mutual funds holding
arrow
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world. The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
personal

Grow your wealth with more research recommendations

+91